Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, replacing the previous version. This likely reflects a behind-the-scenes maintenance update.
    Difference
    0.0%
    Check dated 2026-03-12T02:19:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The site update introduces revision 3.4.2 and removes the prior funding-status notices (3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:00:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide government funding status notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:57:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display added; minor labeling and revision metadata updates were implemented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:50:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The update shows a new revision label (v3.3.4) replacing the previous v3.3.3. No study data or essential details appear to be changed.
    Difference
    0.0%
    Check dated 2026-01-14T02:17:55.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Expanded the Locations section to include sites across Arizona, California, Connecticut, Florida, Illinois, Maryland, Minnesota, Missouri, Nevada, New Mexico, New York, Ohio, Oklahoma, Oregon, Tennessee, Texas, and Virginia, and noted Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T17:31:17.000Z thumbnail image

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.